Affimed N.V. ( AFMD) - Key Metrics
Stock symbol AFMD is outdated, potentially delisted? Maybe it is available on other exchange?
AFMD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.01 | -$0.94 | -$0.69 | -$0.69 |
| 2024Q2 | $0.01 | -$1.01 | -$1.08 | -$1.08 |
| 2024Q1 | $0.01 | -$1.27 | -$1.57 | -$1.57 |
| 2023Q4 | $0.03 | -$1.35 | -$1.70 | -$1.74 |
| 2023Q3 | $0.13 | -$1.63 | -$1.22 | -$1.44 |
AFMD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -0.80 |
| 2024Q2 | ? | -1.25 |
| 2024Q1 | ? | -1.17 |
| 2023Q4 | ? | -1.05 |
| 2023Q3 | ? | -0.69 |
AFMD
Price: $0.18
52 week price:
Earnings Per Share: -5.09 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 1.5 million
Ebitda: -9.1 millionMarket Capitalization: 3.0 million